MDL | MFCD22580421 |
---|---|
Molecular Weight | 315.32 |
Molecular Formula | C12H7F2NO3S2 |
SMILES | CC(C1=CC([N+]([O-])=O)=C(SC2=CC=C(F)C=C2F)S1)=O |
P 22077 is a cell-permeable ubiquitin-specific protease 7 (USP7) inhibitor with an EC 50 of 8.01 μM. P 22077 also inhibits USP47 with an EC 50 of 8.74 μM.
EC50: 8.01 μM (USP7), 8.74 μM (USP47) [1]
P 22077 is an inhibitor of USP7 and DUB USP47, with EC 50 s of 8.01 μM and 8.74 μM, respectively. P 22077 (15-45 μM) inhibits a much smaller subset of DUBs. P 22077 (25 μM) causes DUBs inhibition in HEK293T cells [1] . P 22077 (0-20 μM) greatly reduces the cell viability of Neuroblastoma (NB) cells including IMR-32, NGP, CHLA-255, and SH-SY5Y cells but without NB-19 and SK-N-AS cells. P 22077 (10 μM) increases p53 activity and induces apoptosis in p53 wild-type and HDM2-expressing NB cells. P 22077 (5 μM) enhances the cytotoxic effect of Dox and VP-16 on NB cells, and enhances Dox- and VP-16-induced p53-mediated apoptosis [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
P 22077 (15 mg/kg, i.p. 21 days) shows potent antitumor activities in an xenograft mouse model bearing IMR-32-derived tumors; P 22077 also exhibits antitumor effects after treatment at 10 mg/kg for 14 days in mice bearing SH-SY5Y-derived tumors, and at 20 mg/kg for 12 days in mice bearing NGP-derived tumors [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 50 mg/mL ( 158.57 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.1714 mL | 15.8569 mL | 31.7138 mL |
5 mM | 0.6343 mL | 3.1714 mL | 6.3428 mL |
10 mM | 0.3171 mL | 1.5857 mL | 3.1714 mL |
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (7.93 mM); Clear solution